Breaking news

“You measure a democracy by the freedom it gives its dissidents, more In one of the biggest leaks ever of offshore financial records, the more The Champaran Foundation, in collaboration with InFeed, is inviting entries more The recently concluded German elections on September 26, 2021 have given a more According to latest news reports, China has been on a defense infrastructure more A new line of argument has already come to dominate the public sphere: it’ more The government has gone one step further to detect community spread of the more The government has issued an order to abolish the six allowances, including more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected more SEOUL| South Korea’s unemployment rate was unchanged in April as the more Amid the outbreak of Corona pandemic in the country, Indian government has more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated more Corona infection in the country is taking a macabre form. So far, more than 74 more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh more

After UK, All Eyes on India to Approve Oxford Vaccine

Corona Vaccine

Corona virus cases are increasing in the country. The Corona vaccine is expected to arrive on the new year. In the same sequence, on Wednesday, an expert panel of Drugs Controller of India (DCI) is meeting to give emergency approval to Vaccine Covishield of Serum Institute of India (SII), one of the vaccine manufacturers in India. When the vaccine was approved in the UK, SII executive officer Adar Poonawala said this was good news.

A government official says the Subject Expert Committee (SEC) of the Drugs Controller of India (DCI) is holding a meeting to consider Serum Institute of India’s application for emergency use approval of the Covid-19 vaccine.

Vaccine approval in the UK is a major achievement for the Serum Institute, as it is one of the top three vaccine manufacturers in India. The serum has already applied to the Drug Controller General of India for regulatory approval, but has not yet received mandatory approval for the vaccine. There is a possibility that it may be approved in today’s meeting.

Story Page